Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco increased transportation between Vladivostok and China

10/29/24 FESH

Lenta reported for 9 months of 2024 by RAS

10/29/24 LENT

Lambumize IPO went under the bottom line

10/29/24 LMBZ

Lenzoloto reported for 9 months of 2024 by RAS

10/29/24 LNZL

Bashinformsvyaz reported for 9 months of 2024 by RAS

10/29/24 BISVP

VTB reports for 9 months of 2024 by RAS

10/29/24 VTBR

Gazprom reported for 9 months of 2024 by RAS

10/29/24 GAZP

IK RUSS-INVEST reported for 9 months of 2024 by RAS

10/29/24 RUSI

DIOD reported for 9 months of 2024 by RAS

10/29/24 DIOD

Astra and Arenadata agree on strategic partnership

10/29/24 ASTR